对《达莫凝血因子α聚乙二醇化：A型血友病综述》的勘误
Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A.
作者信息
Paik Julia, Deeks Emma D
机构信息
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
出版信息
Drugs. 2019 Sep;79(13):1495. doi: 10.1007/s40265-019-01190-1.
Abstract
The article Damoctocog Alfa Pegol: A Review in Haemophilia A, written by Julia Paik and Emma D. Deeks, was originally published Online First without open access.
摘要
朱莉娅·派克（Julia Paik）和艾玛·D·迪克斯（Emma D. Deeks）撰写的《达莫凝血因子α聚乙二醇：血友病A综述》一文最初以在线优先形式发表，无开放获取权限。
相似文献
1
Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A.对《达莫凝血因子α聚乙二醇化：A型血友病综述》的勘误
Drugs. 2019 Sep;79(13):1495. doi: 10.1007/s40265-019-01190-1.
2
Damoctocog Alfa Pegol: A Review in Haemophilia A.达莫曲奥珠单抗：用于治疗 A 型血友病的综述。
Drugs. 2019 Jul;79(10):1147-1156. doi: 10.1007/s40265-019-01152-7.
3
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: analysis from the PROTECT VIII study.达莫妥珠单抗α聚乙二醇预防治疗对年龄≥40岁的重度甲型血友病合并症患者的疗效与安全性：来自PROTECT VIII研究的分析
Ther Adv Hematol. 2023 Apr 22;14:20406207231166779. doi: 10.1177/20406207231166779. eCollection 2023.
4
Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia A.HEM-POWR 研究设计：一项前瞻性、观察性研究，评估达特昔尤单抗治疗真实世界中 A 型血友病患者的疗效。
BMJ Open. 2021 Sep 2;11(9):e044997. doi: 10.1136/bmjopen-2020-044997.
5
Damoctocog Alfa Pegol for Hemophilia A Prophylaxis: An Italian Multicenter Survey.聚乙二醇化重组人凝血因子VIII用于A型血友病预防：一项意大利多中心调查。
Pharmaceuticals (Basel). 2023 Aug 22;16(9):1195. doi: 10.3390/ph16091195.
6
Correction to: Nonacog Beta Pegol: A Review in Haemophilia B.对《重组人凝血因子IX聚乙二醇化修饰物：B型血友病综述》的更正
Drugs. 2018 Jul;78(11):1169. doi: 10.1007/s40265-018-0951-1.
7
Correction to: Cladribine Tablets: A Review in Relapsing MS.《克拉屈滨片：复发型多发性硬化症综述》勘误
CNS Drugs. 2019 Feb;33(2):193. doi: 10.1007/s40263-019-00604-8.
8
Correction to: Tapentadol Prolonged Release: A Review in Pain Management.对《缓释曲马多：疼痛管理综述》的勘误
Drugs. 2019 Apr;79(5):589. doi: 10.1007/s40265-019-01102-3.
9
Correction to: Sarecycline: First Global Approval.对《Sarecycline：首次全球获批》的勘误
Drugs. 2019 May;79(7):795. doi: 10.1007/s40265-019-01122-z.
10
Correction to: Vestronidase Alfa: A Review in Mucopolysaccharidosis VII.更正：维斯特罗尼酶α：黏多糖贮积症VII的综述。
BioDrugs. 2019 Jun;33(3):343. doi: 10.1007/s40259-019-00353-6.
Zotero 插件